27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
At the end of June, the U.S. Supreme Court issued an important Freedom of Information Act (FOIA) dec...
Read More >
If asked to describe the essential functions of a given job, most employers would include actually s...
Read More >
A lot of times, determining whether a worker is an independent contractor or an employee is tough. ...
Read More >
The global effect of the Coronavirus disease (COVID-19) is still unknown, and the progress of many l...
Read More >
In this five-part podcast series, I visit with Terry L Orr, a Managing Director at Kroll, a division...
Read More >
Employers and plan sponsors must comply with numerous filing and notice deadlines for their retireme...
Read More >